Pharma

Expecting mothers face numerous health considerations, one of the most vital being the safe use of medications. The safety concerns double down for pregnant...

The complexities of dealing with chronic Chagas disease (CCD) in Latin America extend beyond health, with communities grappling with significant economic challenges. Though the...

Gender disparities in HIV outcomes persist across multiple regions, influencing public health strategies across the continent. The latest research provides a meticulous analysis using...

In recent developments concerning pharmacovigilance within the European Union, the European Medicines Agency (EMA) has executed its periodic safety update report single assessment (PSUSA)...

Nasopharyngeal carcinoma (NPC), a formidable oncological adversary, often proves challenging to treat, especially in cases that are recurrent or have metastasized. The emergence of...

A milestone in the realm of neurodegenerative disease diagnostics, Amyvid presents a seamless fusion of radiopharmaceutical innovation and clinical precision for Alzheimer's detection. By...

Ozenoxacin, a widely used antibiotic, undergoes a critical safety evaluation within the European Union as part of a comprehensive regulatory process. As a systematic...

In November 2025, the Paediatric Committee (PDCO) convened to discuss the progress and status of various paediatric investigation plans and compliance checks, revealing a...

With the advent of combined antiretroviral therapy (cART), the management of HIV has entered a new era where the disease can be transformed into...

Ipsen has taken another significant step in addressing neurological conditions by presenting new data at the TOXINS 2026 conference in Madrid, Spain. Their presentation...

Gene therapy holds great promise for treating hemophilia, offering potential long-term solutions to those with hemophilia A and B. Yet, addressing its financial and...

In a bold move to address the expanding needs of dry eye sufferers, TheraTears® has unveiled two groundbreaking products aimed at enhancing ocular comfort...

In a significant development for osteoporosis treatment options, Terrosa has received endorsement for use across the European Union. The approval marks an important milestone...

As we propel into an era dominated by technology, companies are increasingly seeking innovative solutions to meet the growing consumer demand. This rising tide...

In a leap forward for oncology treatments, Abevmy, a novel cancer medication, gains significant traction across Europe. With its authorization by the European Union,...